Switch to Documented Risk-Based V&V, Failure Investigation and Root Cause Analysis

This webinar will review a company's process verification and validation system for major cGMP deficiencies. It will address the FDA's newer and tougher regulatory stance, and offer an understanding on how the FDA's recent process validation guidance for pharma can assist all regulated industries meet regulatory requirements.

Why Should You Attend:

FDA Warning Letters and recent high-profile recalls indicate major cGMP deficiencies in big name device and pharma companies. And now the FDA is taking an even tougher stance. 

Who Will Benefit:

This webinar will provide valuable assistance to all regulated companies that need to review and modify their Process Validation Planning and Execution / Documentation.

Senior management

Regulatory Affairs

Quality Assurance

Production

Instructor Profile:

John E. Lincoln is principal of J. E. Lincoln and Associates LLC, a consulting company with over 33 years' experience in U.S. FDA regulated industries, 19 of which are as an independent consultant. He has worked with companies from start-up to Fortune 100 in the U.S., Mexico, Canada, France, Germany, Sweden, China and Taiwan.

Note:

Use coupon code NB5SQH8N and get 10% off on registration, Valid till Dec 31st 2015.

For Registration:

http://www.complianceonline.com/switch-to-documented-risk-based-v&v-failure-investigation-and-root-cause-analysis-webinar-training-704209-prdw?channel=sciencedz